Literature DB >> 2235074

A comparison of multiplication rates in primary and challenge infections of Trypanosoma brucei bloodstream forms.

L M McLintock1, C M Turner, K Vickerman.   

Abstract

The hypothesis that division of Trypanosoma brucei slender bloodstream forms is dependent upon the availability of a host-derived growth factor has been tested by superimposing challenge doses of slender-form trypanosomes onto preexisting infections at a time during the primary infection when stumpy forms predominated. The challenge populations grew in the doubly-infected mice indicating that depletion of a putative growth factor by the expanding population of the primary infection had not prevented division of the trypanosomes although slight reductions in multiplication rates were observed. This effect was independent of the variable antigen type (VAT) of the trypanosomes and of their stock of origin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2235074     DOI: 10.1017/s0031182000079749

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  4 in total

1.  Limitation of Trypanosoma brucei parasitaemia results from density-dependent parasite differentiation and parasite killing by the host immune response.

Authors:  K M Tyler; P G Higgs; K R Matthews; K Gull
Journal:  Proc Biol Sci       Date:  2001-11-07       Impact factor: 5.349

2.  The bloodstream differentiation-division of Trypanosoma brucei studied using mitochondrial markers.

Authors:  K M Tyler; K R Matthews; K Gull
Journal:  Proc Biol Sci       Date:  1997-10-22       Impact factor: 5.349

3.  Inhibition of growth of Trypanosoma brucei parasites in chronic infections.

Authors:  C M Turner; N Aslam; S D Angus
Journal:  Parasitol Res       Date:  1996       Impact factor: 2.289

4.  T-Cell responses during Trypanosoma brucei infections in mice deficient in inducible nitric oxide synthase.

Authors:  A E Millar; J Sternberg; C McSharry; X Q Wei; F Y Liew; C M Turner
Journal:  Infect Immun       Date:  1999-07       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.